Clinical Trials Directory

Trials / Completed

CompletedNCT03216512

Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD

A Randomized, Sham-Controlled, Crossover Study to Evaluate the Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in Children and Adolescents Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
6 Years – 17 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate performance on the Attention Deficit Hyperactivity Disorder ( ADHD) Battery of the Cambridge Automated Neuropsychological Test Battery (CANTAB), including spatial working memory, inhibitory control, and attention while using either a noise cancelling headphone or sham headphone control in the presence of standardized auditory distractors in children and adolescents with ADHD.

Detailed description

This will be a proof-of-concept, randomized, within-subject cross-over design with the administration of noise cancelling headphones or sham headphones on two separate study days. Following screening and a baseline assessment session with no headphones, participants will be assigned to complete each experimental session. During each session, they will undergo the CANTAB and Academic tasks. The order of sessions will be randomized and balanced across participants to be either noise-cancelling headphones first followed by sham headphones; or sham headphones first followed by noise-cancelling headphones. Eligible participants currently taking stimulant medications for ADHD will be asked to stop taking their medication on the day of the baseline visit and during the 2 experimental sessions.

Conditions

Interventions

TypeNameDescription
OTHERUse of Noise Cancelling HeadphonesDuring the 2 experimental sessions, participants will complete study assessments using either a noise cancelling headphone first (session 1) and then sham control second ( session 2), or vice versa, in the presence of noise distractions.

Timeline

Start date
2018-09-21
Primary completion
2019-01-31
Completion
2019-01-31
First posted
2017-07-13
Last updated
2020-01-18
Results posted
2020-01-18

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03216512. Inclusion in this directory is not an endorsement.